Antiretroviral News and Research

RSS

U.N., U.S. re-evaluate HIV/AIDS treatment targets

Ahead of the U.N. High Level Meeting on AIDS, scheduled for June 8-10 in New York, "public-health leaders face a paradox: New evidence suggests the epidemic can finally be controlled, but that would demand increased spending at a time of severe global budget restraints," the Wall Street Journal reports.

27 May 2011

Recent releases in Global Health

As the G8 summit began in Deauville, France, on Thursday, David Olson, the council's director of policy communications, wrote on the Global Health Council's "Blog 4 Global Health" that "global health is nowhere visible on the agenda," which "is in striking contrast to the final communique of the G8 Muskoka, which devoted a significant amount of space to health" (5/26).

27 May 2011

Mylan plans to change name of Matrix Laboratories

Mylan Inc. today announced that it plans to rebrand its Hyderabad, India-based subsidiary Matrix Laboratories Limited as Mylan.

27 May 2011

Ahead of U.N. General Assembly meeting next month, IPS examines global funding shortfall for HIV/AIDS treatment

Inter Press Service examines the global funding shortfall for antiretroviral treatment programs for people living with HIV/AIDS, noting that the U.N. General Assembly High Level Meeting on AIDS next month in New York "will shape the direction of the global response to HIV and AIDS for the next decade and beyond."

25 May 2011

Study offers hope for reducing incidence of AIDS with potential preventive vaccine

The HIV epidemic is the largest in the world and represents one of the most serious public health problems, according to data from the World Health Organization. Only 30% of the more than 10 million patients in need have the access to the antiretroviral treatment.

24 May 2011

HIV prevention study results raise public health questions about forcing patients into treatment

A New York Times "Week In Review" article examines how the results of a recent study showing combination antiretroviral therapy can reduce the risk of HIV transmission by 96 percent "reopens old questions" about the rightsof patients to refuse therapy and whether doctors, in the interest of public health, should force patients to start treatment.

24 May 2011

Kenyan HIV/AIDS advocates ask government to boost health funding

IRIN/PlusNews reports that hundreds of Kenyan HIV/AIDS advocates took to the streets of Nairobi on Wednesday "to demand that the government meet its commitment to increase annual health and HIV funding."

21 May 2011

Edurant receives FDA approval for treatment of HIV-1 infection

The U.S. Food and Drug Administration today approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy (treatment-naive).

21 May 2011

AIDS mortality in China drops by nearly two thirds since 2002 when country began free treatment program

China's HIV/AIDS-related mortality has dropped from 39.3 per 100 person-years in 2002 to 14.2 in 2009, or 64 percent, since the nation began providing free antiretroviral therapy (ART) in 2002, according to a study conducted by researchers from the Chinese Center for Disease Control and Prevention and published online Wednesday in Lancet Infectious Diseases, the New York Times reports (McNeil, 5/18).

20 May 2011

AVAC calls on donors, policy makers to strengthen support for AIDS vaccine research

This year HIV Vaccine Awareness Day comes at the dawn of a true prevention revolution that could finally turn the tide of the AIDS epidemic. AIDS vaccine research is a critical part of that revolution and on this day AVAC calls on donors, policy makers and others to strengthen support for AIDS vaccine research.

19 May 2011

Opinion: Study will unite HIV advocates, add funding pressure to Obama administration

In a post on Foreign Policy's "Passport" blog, assistant managing editor Elizabeth Dickinson looks at the potential ramifications of a recent study, which found that early antiretroviral treatment in HIV-positive people can prevent transmission by 96 percent.

18 May 2011

Antiretrovirals important to protect HIV-positive children from measles

Scientific American looks at the possible link between HIV prevalence and a recent increase in the number of children dying from measles in sub-Saharan Africa. "Studies show that infants with HIV do not respond well to the measles vaccine even when given a second dose at nine months, as the World Health Organization currently recommends," the article notes.

17 May 2011

Opinion: New HIV infections more expensive than providing antiretroviral drugs to existing patients

In light of study findings released last week showing the risk of HIV transmission can be reduced by 96 percent if HIV-positive patients begin combination antiretroviral therapy as soon as possible, a San Francisco Chronicle editorial asks, "The evidence is clearly starting to show that it's much better to treat patients earlier, but from where will the money come?".

17 May 2011

Study: HIV treatment drugs slash transmission risk

AIDS researchers offered evidence backing up the long-standing idea that people infected with HIV who are being treated are much less likely to transmit the virus than those who are not on drugs. This finding is being hailed as a breakthrough.

16 May 2011

Early HIV treatment can reduce transmission risk by 96%, preliminary study results show

Preliminary results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday " in what is being hailed as a breakthrough in HIV prevention," the Los Angeles Times reports.

16 May 2011

AIDS spread prevention by vaccine and anti HIV drugs

A latest vaccine against HIV/AIDS has shown to be effective in monkeys and has protected macaques the most widespread primate genus, against the monkey equivalent of HIV, Simian immunodeficiency virus (SIV). This could provide a fresh approach to an HIV vaccine, a study suggests. US researchers say the vaccine offered protection to 13 of 24 Rhesus macaques treated in the experiment. In 12 of the monkeys, the vaccine was still effective 12 months later.

15 May 2011

Early treatment of HIV makes infection transmission less likely: Study

“It's a game-changer,” Michel Sidibe, executive director of UNAIDS, said. “I am completely amazed.” It was noted that anti-HIV drugs called antiretroviral drugs can suppress HIV in an infected patient and also help to prevent its spread through intercourse, he said. He predicted a rethink of the strategies that have evolved since the first cases of AIDS were recorded in June 1981. “The implications are multiple,” said Mr Sidibe. “However, money will be the major challenge.”

15 May 2011

Scientists 'tinker' with HIV drug chemistry hoping to reduce costs

The Clinton Health Access Initiative, founded by former President Bill Clinton, with funding from the Bill & Melinda Gates Foundation and the U.K. government, has hired former pharmaceutical company scientists "to tinker with the chemistry used to synthesize a key [HIV] drug, tenofovir" in an effort to reduce "the cost of manufacturing," the Wall Street Journal reports.

13 May 2011

Early antiretroviral treatment can halt HIV spread in couples

A research study led by the University of North Carolina at Chapel Hill has made a major discovery in the effort to halt the spread of HIV, the virus that causes AIDS.

13 May 2011

Antiretroviral therapy can reduce risk of HIV transmission in couples

When one partner in a couple is infected with HIV and the other is not, treatment with antiretroviral drugs can dramatically lower the chances of the infected partner passing along the disease to his or her mate, a new evidence review finds.

12 May 2011

Antiretroviral News and Research

U.N., U.S. re-evaluate HIV/AIDS treatment targets

Recent releases in Global Health

Mylan plans to change name of Matrix Laboratories

Ahead of U.N. General Assembly meeting next month, IPS examines global funding shortfall for HIV/AIDS treatment

Study offers hope for reducing incidence of AIDS with potential preventive vaccine

HIV prevention study results raise public health questions about forcing patients into treatment

Kenyan HIV/AIDS advocates ask government to boost health funding

Edurant receives FDA approval for treatment of HIV-1 infection

AIDS mortality in China drops by nearly two thirds since 2002 when country began free treatment program

AVAC calls on donors, policy makers to strengthen support for AIDS vaccine research

Opinion: Study will unite HIV advocates, add funding pressure to Obama administration

Antiretrovirals important to protect HIV-positive children from measles

Opinion: New HIV infections more expensive than providing antiretroviral drugs to existing patients

Study: HIV treatment drugs slash transmission risk

Early HIV treatment can reduce transmission risk by 96%, preliminary study results show

AIDS spread prevention by vaccine and anti HIV drugs

Early treatment of HIV makes infection transmission less likely: Study

Scientists 'tinker' with HIV drug chemistry hoping to reduce costs

Early antiretroviral treatment can halt HIV spread in couples

Antiretroviral therapy can reduce risk of HIV transmission in couples

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News